Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes

被引:54
作者
Doll, MA [1 ]
Hein, DW [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
关键词
D O I
10.1006/abio.2000.4892
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:106 / 108
页数:3
相关论文
共 19 条
[1]   GENOTYPE-PHENOTYPE DISCORDANCE FOR HUMAN ARYLAMINE N-ACETYLTRANSFERASE (NAT2) REVEALS A NEW SLOW-ACETYLATOR ALLELE COMMON IN AFRICAN-AMERICANS [J].
BELL, DA ;
TAYLOR, JA ;
BUTLER, MA ;
STEPHENS, EA ;
WIEST, J ;
BRUBAKER, LH ;
KADLUBAR, FF ;
LUCIER, GW .
CARCINOGENESIS, 1993, 14 (08) :1689-1692
[2]   Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay [J].
Bigler, J ;
Chen, C ;
Potter, JD .
BIOTECHNIQUES, 1997, 22 (04) :682-&
[3]   Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes [J].
Blömeke, B ;
Sieben, S ;
Spötter, D ;
Landt, O ;
Merk, HF .
ANALYTICAL BIOCHEMISTRY, 1999, 275 (01) :93-97
[4]   MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS [J].
BLUM, M ;
DEMIERRE, A ;
GRANT, DM ;
HEIM, M ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5237-5241
[5]  
CASCORBI I, 1995, AM J HUM GENET, V57, P581
[6]  
Deitz AC, 2000, CANCER EPIDEM BIOMAR, V9, P905
[7]   DETERMINATION OF HUMAN NAT2 ACETYLATOR GENOTYPE BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND ALLELE-SPECIFIC AMPLIFICATION [J].
DOLL, MA ;
FRETLAND, AJ ;
DEITZ, AC ;
HEIN, DW .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (02) :413-420
[8]   Pharmacogenomics: Translating functional genomics into rational therapeutics [J].
Evans, WE ;
Relling, MV .
SCIENCE, 1999, 286 (5439) :487-491
[9]  
Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29
[10]   ACETYLATOR GENOTYPE AND ARYLAMINE-INDUCED CARCINOGENESIS [J].
HEIN, DW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :37-66